Cargando…

Clinical practice guidelines adherence, knowledge and awareness in rare and complex connective tissue diseases across Europe: results from the first ERN ReCONNET survey

INTRODUCTION: The European Reference Network (ERN) ReCONNET is the ERN aimed at improving the management of rare and complex connective tissue and musculoskeletal diseases (rCTDs) across the European Union (EU). In the mission of ERN ReCONNET, clinical practice guidelines (CPGs) play a crucial role,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Talarico, Rosaria, Marinello, Diana, Bombardieri, Stefano, Burmester, Gerd, Fonseca, Joao, Frank, Charissa, Galetti, Ilaria, Hachulla, Eric, Houssiau, Frederic, Mueller-Ladner, Ulf, Schneider, Matthias, Smith, Vanessa, Turchetti, Giuseppe, van Laar, Jacob M, Vieira, Ana, Cutolo, Maurizio, Mosca, Marta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Connective Tissue Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7507993/ https://www.ncbi.nlm.nih.gov/pubmed/32868449 http://dx.doi.org/10.1136/rmdopen-2020-001344

Ejemplares similares

Clinical practice guidelines: the first year of activity of the European Reference Network on Rare and Complex Connective Tissue and Musculoskeletal Diseases (ERN ReCONNET)
por: Mosca, Marta, et al.
Publicado: (2018)

The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
por: Talarico, Rosaria, et al.
Publicado: (2021)

Publisher Correction: The impact of COVID-19 on rare and complex connective tissue diseases: the experience of ERN ReCONNET
por: Talarico, Rosaria, et al.
Publicado: (2022)

An overlook on the current registries for rare and complex connective tissue diseases and the future scenario of TogethERN ReCONNET
por: Bandeira, Matilde, et al.
Publicado: (2022)

IgG4-related diseases: state of the art on clinical practice guidelines
por: Iaccarino, Luca, et al.
Publicado: (2019)

Ehlers-Danlos syndromes: state of the art on clinical practice guidelines
por: Sulli, Alberto, et al.
Publicado: (2018)

Idiopathic inflammatory myopathies: state of the art on clinical practice guidelines
por: Meyer, Alain, et al.
Publicado: (2019)

Mixed connective tissue disease: state of the art on clinical practice guidelines
por: Chaigne, Benjamin, et al.
Publicado: (2018)

Relapsing polychondritis: state of the art on clinical practice guidelines
por: Rednic, Simona, et al.
Publicado: (2018)

Exploring patient’s experience and unmet needs on pregnancy and family planning in rare and complex connective tissue diseases: a narrative medicine approach
por: Marinello, Diana, et al.
Publicado: (2022)

Undifferentiated connective tissue disease: state of the art on clinical practice guidelines
por: Antunes, Margarida, et al.
Publicado: (2019)

Rare diseases under different levels of economic analysis: current activities, challenges and perspectives
por: Cannizzo, Sara, et al.
Publicado: (2018)

SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies
por: Graf, Manuel, et al.
Publicado: (2022)

Understanding the value of non-specific abnormal capillary dilations in presence of Raynaud’s phenomenon: a detailed capillaroscopic analysis
por: Pacini, Greta, et al.
Publicado: (2022)

Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort
por: Truchetet, Marie-Elise, et al.
Publicado: (2022)

Microvascular damage in autoimmune connective tissue diseases: a capillaroscopic analysis from 20 years of experience in a EULAR training and research referral centre for imaging
por: Hysa, Elvis, et al.
Publicado: (2023)

Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS Cohort
por: Carvajal Alegria, Guillermo, et al.
Publicado: (2016)

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study
por: Abisror, Noemie, et al.
Publicado: (2020)

Fatigue in primary Sjögren's syndrome is associated with lower levels of proinflammatory cytokines
por: Howard Tripp, Nadia, et al.
Publicado: (2016)

An Opportunity to Harmonise the Approach to Patients' Care Pathways for Rare and Complex Diseases: RarERN Path™
por: Talarico, Rosaria, et al.
Publicado: (2022)

Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry
por: Yeoh, Su-Ann, et al.
Publicado: (2022)

A prediction model for progressive disease in systemic sclerosis
por: Meijs, Jessica, et al.
Publicado: (2015)

EULAR Sjögren's syndrome disease activity index (ESSDAI): a user guide
por: Seror, Raphaèle, et al.
Publicado: (2015)

ACPA-positive primary Sjögren's syndrome: true primary or rheumatoid arthritis-associated Sjögren's syndrome?
por: Payet, J, et al.
Publicado: (2015)

Dermatomyositis flare on imiquimod therapy highlights a crucial role of aberrant TLR7 signalling
por: Meyer, Alain, et al.
Publicado: (2016)

EULAR/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report
por: Bottai, Matteo, et al.
Publicado: (2017)

Long-term efficacy and safety of antitumour necrosis factor alpha treatment in rhupus: an open-label study of 15 patients
por: Danion, François, et al.
Publicado: (2017)

Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores
por: van den Hoogen, Lucas L, et al.
Publicado: (2018)

Prevalence and clinical correlates of rheumatoid factor and anticitrullinated protein antibodies in patients with idiopathic inflammatory myopathy
por: Ide, Veerle, et al.
Publicado: (2018)

Humanised effector-null FcγRIIA antibody inhibits immune complex-mediated proinflammatory responses
por: Chen, Bo, et al.
Publicado: (2019)

Distinct interferon signatures stratify inflammatory and dysimmune myopathies
por: Rigolet, Muriel, et al.
Publicado: (2019)

Pulmonary arterial hypertension, a novelty in idiopathic inflammatory myopathies: insights and first experiences with vasoactive therapy
por: Bhansing, Kavish J, et al.
Publicado: (2017)

MRI of skeletal muscles in patients with idiopathic inflammatory myopathies: characteristic findings and diagnostic performance in dermatomyositis
por: Ukichi, Taro, et al.
Publicado: (2019)

Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults
por: Tektonidou, Maria G, et al.
Publicado: (2019)

Seasonal and residential clustering at disease onset of anti-MDA5-associated interstitial lung disease
por: Nishina, Naoshi, et al.
Publicado: (2020)

All-cause mortality in systemic rheumatic diseases under treatment compared with the general population, 2015–2019
por: Bournia, Vasiliki-Kalliopi, et al.
Publicado: (2021)

Suitability for e-health of non-pharmacological interventions in connective tissue diseases: scoping review with a descriptive analysis
por: Ritschl, Valentin, et al.
Publicado: (2021)

Pseudoacrocyanosis: a case for telemedicine in rheumatology
por: Manger, Bernhard, et al.
Publicado: (2022)

Remote self-collection of capillary blood using upper arm devices for autoantibody analysis in patients with immune-mediated inflammatory rheumatic diseases
por: Zarbl, Joshua, et al.
Publicado: (2022)

Efficacy and safety of dose escalation of tofacitinib in refractory anti-MDA5 antibody-positive dermatomyositis
por: Ida, Tomoaki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d2thijdldnr7ce95k1115vbn0h